Does TOFACITINIB Cause Pulmonary oedema? 153 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 153 reports of Pulmonary oedema have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
153
Reports of Pulmonary oedema with TOFACITINIB
0.1%
of all TOFACITINIB reports
12
Deaths
99
Hospitalizations
How Dangerous Is Pulmonary oedema From TOFACITINIB?
Of the 153 reports, 12 (7.8%) resulted in death, 99 (64.7%) required hospitalization, and 9 (5.9%) were considered life-threatening.
Is Pulmonary oedema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 153 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Pulmonary oedema?
ADALIMUMAB (1,196)
MACITENTAN (1,019)
SACUBITRIL\VALSARTAN (958)
DASATINIB (873)
TREPROSTINIL (866)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (783)
AMLODIPINE (774)
LENALIDOMIDE (706)
FUROSEMIDE (571)
IBRUTINIB (494)
Which TOFACITINIB Alternatives Have Lower Pulmonary oedema Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN